Theriva Biologics, Inc. - COM NEW (TOVX)

Historical Portfolio Holders from Q3 2022 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
1.39M
Holdings value Q2 2024
$328K
Value change Q2 2024
+$131K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
20
Number of buys Q2 2024
0
Number of sells Q2 2024
-1
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 0 $0 -$86 0
2024 Q2 1.39M $328K +$131K $0.24 20
2024 Q1 792K $1.37M -$122K $0.47 22
2023 Q4 1.05M $452K -$7.4K $0.43 23
2023 Q3 1.06M $573K +$27K $0.54 20
2023 Q2 1.01M $1.01M -$20.9K $1.00 17
2023 Q1 1.04M $725K +$2.17K $0.70 17
2022 Q4 1.05M $479K -$113K $0.45 18
2022 Q3 1.16M $1.14M +$1.14M $0.98 16